There is a version of diversion monitoring that looks like this: a facility purchases a software platform, configures it to pull from the ADC and the EHR, watches the alerts populate, and considers its detection program complete.
I understand why it happens. The investment is significant. The technology is impressive. And after years of trying to monitor controlled substances through manual review and periodic audits, a platform that surfaces anomalies automatically feels like a solution.
It is part of a solution. It is not the whole thing.
The facilities that get real value from diversion monitoring software are not necessarily the ones with the most sophisticated platforms. They are the ones that have built the human infrastructure around the technology — the trained investigators, the defined response protocols, the leadership accountability — that turns a software alert into a meaningful outcome.
Without that infrastructure, even the best platform becomes an expensive alert queue that no one is adequately equipped to act on.
If your facility has invested in diversion monitoring software but is not confident that your program infrastructure matches the technology, that gap is worth examining. Schedule a free 30-minute assessment with Rxpert Solutions — that is exactly the kind of gap assessment we do.
What the software does well
The capabilities that make diversion monitoring software genuinely valuable are the ones human review cannot replicate at scale.
Pattern recognition across large datasets is the most significant. A pharmacist manually reviewing ADC logs might catch an obvious anomaly. What no one can do manually is simultaneously analyze transaction patterns across dozens of staff members, multiple medications, multiple shifts, and multiple data sources — looking for the subtle deviations from baseline that precede confirmed diversion by weeks or months. Software can do that.
Behavioral profiling adds another dimension. Rather than evaluating each transaction in isolation, sophisticated platforms build individual and peer group baselines over time and flag meaningful deviations. Diversion rarely looks like an obvious red flag. It looks like a gradual drift from normal — one that is easy to rationalize away until the pattern is examined in its totality.
Multi-source data integration is where the most capable platforms separate themselves. Connecting ADC data with medication administration records, pharmacy verification logs, anesthesia documentation, and scheduling data creates a picture where the gaps and inconsistencies that indicate diversion become visible in ways they simply are not when data sources are examined independently.
Is your current platform configured to actually deliver on these capabilities?
Book a complimentary 30-minute consultation with RXpert Solutions — we help facilities evaluate whether their technology is set up to perform.
What software cannot do
Understanding the limits of the technology is as important as understanding its capabilities — because the most dangerous outcome of a software investment is the false sense of security it creates when the program behind it is inadequate.
Software cannot investigate itself. An alert is the beginning of a process, not the end of one. What happens next depends entirely on the people and processes behind the technology. Who reviews the alert? What is the escalation pathway when it rises to the level of a formal investigation? If those questions do not have clear answers, the alert sits in a queue — and a queue full of unreviewed alerts is not a detection program. It is a liability.
Software cannot replace clinical judgment. Context matters enormously in anomaly review. The technology identifies deviations from baseline. The trained human investigator determines what those deviations mean.
And software cannot build a culture. The speak-up environment, the accountability structures, the staff engagement that makes human observation a meaningful complement to technological monitoring — none of that can be automated. It is built through leadership and organizational commitment.
At Rxpert Solutions, we work with healthcare organizations at every stage of the diversion monitoring software lifecycle — from configuration optimization to building the program infrastructure that makes the technology deliver on its promise.
If your facility has invested in diversion monitoring software and is not confident you are getting full value from that investment, let’s talk. Your first 30 minutes with Rxpert Solutions are free.
— Terri Vidals B.S.Pharm Founder, Rxpert Solutions | Host, Drug Diversion Insights
Available on YouTube, Spotify, LinkedIn, and Substack. rxpert.solutions